Alastair Wilkins
Overview
Explore the profile of Alastair Wilkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
2138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kemp K, Georgievskaya A, Hares K, Redondo J, Bailey S, Rice C, et al.
Nat Commun
. 2022 Aug;
13(1):4655.
PMID: 35945193
Friedreich's ataxia (FA) is an inherited progressive neurodegenerative disease for which there is no proven disease-modifying treatment. Here we perform an open-label, pilot study of recombinant human granulocyte-colony stimulating factor...
2.
Cunniffe N, Vuong K, Ainslie D, Baker D, Beveridge J, Bickley S, et al.
J Neurol Neurosurg Psychiatry
. 2020 Nov;
92(3):295-302.
PMID: 33184094
Objective: To establish a rigorous, expert-led, evidence-based approach to the evaluation of licensed drugs for repurposing and testing in clinical trials of people with progressive multiple sclerosis (MS). Methods: We...
3.
Buckner N, Kemp K, Scott H, Shi G, Rivers C, Gialeli A, et al.
Brain Pathol
. 2020 Jun;
30(6):1041-1055.
PMID: 32580238
SAFB1 is a DNA and RNA binding protein that is highly expressed in the cerebellum and hippocampus and is involved in the processing of coding and non-coding RNAs, splicing and...
4.
Brown J, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, et al.
JAMA
. 2019 Jan;
321(2):175-187.
PMID: 30644981
Importance: Within 2 decades of onset, 80% of untreated patients with relapsing-remitting multiple sclerosis (MS) convert to a phase of irreversible disability accrual termed secondary progressive MS. The association between...
5.
Haynes H, Scott H, Killick-Cole C, Shaw G, Brend T, Hares K, et al.
J Pathol
. 2018 Dec;
247(4):422-434.
PMID: 30565681
The overall survival for patients with primary glioblastoma is very poor. Glioblastoma contains a subpopulation of glioma stem cells (GSC) that are responsible for tumour initiation, treatment resistance and recurrence....
6.
Redondo J, Sarkar P, Kemp K, Heesom K, Wilkins A, Scolding N, et al.
Stem Cells Transl Med
. 2018 Aug;
7(10):748-758.
PMID: 30063300
The potential of autologous cell-based therapies including those using multipotent mesenchymal stromal cells (MSCs) is being investigated for multiple sclerosis (MS) and other neurological conditions. However, the phenotype of MSC...
7.
von Wunster B, Bailey S, Wilkins A, Marks D, Scolding N, Rice C
Pract Neurol
. 2018 Jun;
18(6):472-476.
PMID: 29848512
Given the intuitive potential of stem cell therapy and limitations of current treatment options for progressive multiple sclerosis (MS), it is not surprising that patients consider undertaking significant clinical and...
8.
Kemp K, Dey R, Verhagen J, Scolding N, Usowicz M, Wilkins A
Acta Neuropathol
. 2018 Mar;
135(6):907-921.
PMID: 29541917
Bone marrow-derived cells are known to infiltrate the adult brain and fuse with cerebellar Purkinje cells. Histological observations that such heterotypic cell fusion events are substantially more frequent following cerebellar...
9.
Kemp K, Hares K, Redondo J, Cook A, Haynes H, Burton B, et al.
Ann Neurol
. 2018 Mar;
83(4):779-793.
PMID: 29534309
Objective: Friedreich's ataxia is an incurable inherited neurological disease caused by frataxin deficiency. Here, we report the neuroreparative effects of myeloablative allogeneic bone marrow transplantation in a humanized murine model...
10.
Haynes H, Killick-Cole C, Hares K, Redondo J, Kemp K, Moutasim K, et al.
J Clin Pathol
. 2018 Feb;
71(8):695-701.
PMID: 29463577
Aims: Histopathological tissue samples are being increasingly used as sources of nucleic acids in molecular pathology translational research. This study investigated the suitability of glioblastoma and control central nervous system...